Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
18 Dec 2016 ESMO Asia 2016 Press Release: Immunotherapy with Pembrolizumab Deemed Cost-Effective for Advanced Melanoma Patients in Hong Kong Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
18 Dec 2016 ESMO Asia 2016 Press Release: Routine Blood Test Predicts How Long Cancer Patients Will Survive Palliative and supportive care
18 Dec 2016 ESMO Asia 2016 Press Release: Cancer Costs Leaving Patients in Debt Bioethics, legal and economic issues
18 Dec 2016 ESMO Asia 2016 Press Release: Depressed Patients Are Less Responsive to Chemotherapy Anticancer agents & Biologic therapy
18 Dec 2016 ESMO Asia 2016 Press Release: Anxiety and Depression a Major Issue for Cancer Survivors
18 Dec 2016 ESMO Asia 2016 Press Release: Ribociclib Improves Progression-free Survival in Asian Women with Advanced Breast Cancer Breast cancer
17 Dec 2016 ESMO Asia 2016 Press Release: First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore Sarcomas
16 Dec 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Alectinib for the Treatment of ALK-Positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Dec 2016 ESMO Asia 2016 Press Release: Asian Head and Neck Cancer Patients Live Longer with Immunotherapy than Mixed Race Group Head and neck cancers
15 Dec 2016 EMA Hosts Workshop on Adaptive Pathways Bioethics, legal and economic issues
14 Dec 2016 ESMO Thanks Oncology Nurses for Their Outstanding Contribution in the Review of the Patient Guides
14 Dec 2016 ESMO Asia 2016 Press Release: Almost 20% of Breast Cancer Patients Fail to Complete Prescribed Endocrine Therapy Breast cancer
13 Dec 2016 Clinical Responses and Mutation Clearance After Decitabine in Patients with AML and MDS Translational research - Haematologic malignancies - Anticancer agents & Biologic therapy
12 Dec 2016 PI3K Inhibitor Buparlisib in Combination with Fulvestrant Prolongs PFS Compared to Placebo Plus Fulvestrant Translational research - Anticancer agents & Biologic therapy
09 Dec 2016 CAR T-Cell Immunotherapy Induces Complete Remissions in Patients with Refractory DLBCL Haematologic malignancies - Cancer Immunology and Immunotherapy